Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XP13512 in Restless Legs Syndrome
NCT00365352Phase 3Completed
- Sponsor
- XenoPort, Inc.
- Start
- Aug 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by XenoPort, Inc.. Started Aug 2006; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00365352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365352.